Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Waeber

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Expert Opinion on Emerging Drugs|December 10, 2003
Emerging drugs in migraine treatmentChristian Waeber
Frontiers in Pharmacology|June 21, 2011
Selectivity and specificity of sphingosine-1-phosphate receptor ligands: caveats and critical thinking in characterizing receptor-mediated effectsSalvatore Salomone, Christian Waeber
Circulation Journal : Official Journal of the Japanese Circulation Society|March 18, 2014
Sphingosine-1-phosphate as a potential target for the treatment of myocardial infarctionChristian Waeber, Thomas Walther
Drug News & Perspectives|August 31, 2004
Vascular sphingosine-1-phosphate S1P1 and S1P3 receptorsChristian Waeber, Nicolas Blondeau, Salvatore Salomone
European Journal of Pharmacology|June 14, 2020
Bone regenerative potential of the selective sphingosine 1-phosphate receptor modulator siponimod: In vitro characterisation using osteoblast and endothelial cellsZiad Sartawi, Katie B Ryan, Christian Waeber
Advanced Drug Delivery Reviews|May 15, 2022
Polymer based sustained drug delivery to the ocular posterior segment: barriers and future opportunities for the treatment of neovascular pathologiesRasha A Alshaikh, Christian Waeber, Katie B Ryan
The British Journal of Ophthalmology|May 8, 2021
Sphingosine 1-phosphate, a potential target in neovascular retinal diseaseRasha A Alshaikh, Katie B Ryan, Christian Waeber
Pharmacological Research|September 1, 2017
Sphingosine 1-phosphate (S1P) signalling: Role in bone biology and potential therapeutic target for bone repairZiad Sartawi, Ernestina Schipani, Katie B Ryan, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 10, 2003
Dopamine modulates cell cycle in the lateral ganglionic eminenceNobuyo Ohtani, Tomohide Goto, Christian Waeber, et al.
Frontiers in Pharmacology|July 9, 2019
Immunomodulatory Therapeutic Strategies in StrokeKyle Malone, Sylvie Amu, Anne C Moore, et al.
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Expert Opinion on Emerging Drugs|December 10, 2003
Emerging drugs in migraine treatmentChristian Waeber
Frontiers in Pharmacology|June 21, 2011
Selectivity and specificity of sphingosine-1-phosphate receptor ligands: caveats and critical thinking in characterizing receptor-mediated effectsSalvatore Salomone, Christian Waeber
Circulation Journal : Official Journal of the Japanese Circulation Society|March 18, 2014
Sphingosine-1-phosphate as a potential target for the treatment of myocardial infarctionChristian Waeber, Thomas Walther
Drug News & Perspectives|August 31, 2004
Vascular sphingosine-1-phosphate S1P1 and S1P3 receptorsChristian Waeber, Nicolas Blondeau, Salvatore Salomone
European Journal of Pharmacology|June 14, 2020
Bone regenerative potential of the selective sphingosine 1-phosphate receptor modulator siponimod: In vitro characterisation using osteoblast and endothelial cellsZiad Sartawi, Katie B Ryan, Christian Waeber
Advanced Drug Delivery Reviews|May 15, 2022
Polymer based sustained drug delivery to the ocular posterior segment: barriers and future opportunities for the treatment of neovascular pathologiesRasha A Alshaikh, Christian Waeber, Katie B Ryan
The British Journal of Ophthalmology|May 8, 2021
Sphingosine 1-phosphate, a potential target in neovascular retinal diseaseRasha A Alshaikh, Katie B Ryan, Christian Waeber
Pharmacological Research|September 1, 2017
Sphingosine 1-phosphate (S1P) signalling: Role in bone biology and potential therapeutic target for bone repairZiad Sartawi, Ernestina Schipani, Katie B Ryan, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 10, 2003
Dopamine modulates cell cycle in the lateral ganglionic eminenceNobuyo Ohtani, Tomohide Goto, Christian Waeber, et al.
Frontiers in Pharmacology|July 9, 2019
Immunomodulatory Therapeutic Strategies in StrokeKyle Malone, Sylvie Amu, Anne C Moore, et al.
Pageof 6